Bioscience Neutraceuticals, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced operating loss was USD 3,985 compared to USD 2,950 a year ago. Net loss was USD 9,267 compared to USD 10,981 a year ago. For the nine months, operating loss was USD 471,678 compared to USD 22,957 a year ago. Net loss was USD 471,678 compared to USD 49,731 a year ago. Basic loss per share from continuing operations was USD 0.08 compared to USD 0.01 a year ago.